Sertraline Guide (Zoloft)

Brief Summary

This video provides a concise guide to Sertraline, a commonly used psychiatric medication. It covers key aspects such as its mechanism of action, FDA-approved uses, dosing guidelines, potential side effects, contraindications, and special considerations for specific patient populations like pregnant women and those with liver or kidney impairment. The video also highlights Sertraline's favorable profile in patients with cardiac disease and its effectiveness in treating PTSD, making it a preferred SSRI in many cases.

  • Sertraline (Zoloft) is an SSRI antidepressant that increases serotonin levels in the brain.
  • It is FDA-approved for various conditions, including MDD, OCD, panic disorder, and PTSD.
  • Common side effects include GI issues, insomnia, and sexual side effects.
  • Sertraline is preferred in patients with cardiac disease and effective for PTSD.

Introduction to Sertraline

Sertraline, known by the brand name Zoloft, is an SSRI antidepressant first approved in 1991. It typically appears as a blue oval tablet and primarily works by inhibiting the serotonin transporter, which increases serotonin levels in the brain. Sertraline also secondarily inhibits the dopamine transporter and acts as an inverse agonist at the sigma 1 receptor. It is considered a low-risk and low-cost medication option.

FDA-Approved Uses and Dosing

In adults, Sertraline is FDA-approved for treating major depressive disorder (MDD), premenstrual dysphoric disorder (PMDD), social anxiety disorder, obsessive-compulsive disorder (OCD), panic disorder, and post-traumatic stress disorder (PTSD). In children, it is specifically approved for OCD, but it is often used off-label for other conditions. The typical dosage range is between 50 to 200 mg, with an average half-life of 26 hours. The full therapeutic effects usually take 4 to 6 weeks to manifest, although initial improvements may be seen within 1 to 2 weeks.

Withdrawal, Monitoring, and Common Side Effects

Withdrawal effects can occur upon discontinuation of Sertraline, causing discomfort, but are generally not life-threatening. To minimize these effects, it's recommended to reduce the dose by no more than 50% each week when discontinuing the medication. Sertraline typically does not require monitoring in healthy individuals and is only a weak inhibitor of the CYP2D6 enzyme. Common side effects can affect the gastrointestinal, genitourinary, and neurological systems, with patients often concerned about weight gain, sedation, insomnia, GI issues, and sexual side effects. Compared to other antidepressants, Sertraline has a relatively higher incidence of insomnia and GI side effects.

Rare Side Effects and Contraindications

Rare but serious side effects are associated with Sertraline use. It is relatively contraindicated in patients with a known allergy to Sertraline or those concurrently taking disulfiram, linezolid, MAOIs, methylene blue, pimozide, or thioridazine. Sertraline carries a black box warning for increased suicidal thoughts and behaviors in children and young adults.

Special Cases: Liver, Renal, Pregnancy

Sertraline is cleared by the liver, necessitating dose reductions in patients with liver impairment. Generally, dose adjustments are not required for those with renal impairment. Sertraline is often a preferred antidepressant for pregnant patients and is present in breast milk.

Dosing Guidelines for MDD

For major depressive disorder (MDD), the initial dose of Sertraline is 50 mg for adults, 25 mg for children aged 6 to 18, and 25 mg for individuals 65 and older. The FDA-recommended maximum dose is 200 mg for both adults and children. The goal dose for adults with MDD is typically 150 to 200 mg, although doses up to 300 mg have been used. For generalized anxiety disorder (GAD) in adults, the goal dose is 50 to 150 mg, and for OCD in adults, it is 150 to 200 mg, with some patients benefiting from doses up to 400 mg. Pediatric patients generally require lower goal doses, while geriatric patients follow the same goal doses as adults. The usual titration schedule involves increasing the dose by 25 to 50 mg weekly for adults, with slower adjustments for children.

Final Tips and Advantages of Sertraline

Sertraline has strong evidence supporting its safety in patients with cardiac disease, making it a preferred choice in these cases. It is also one of the few antidepressants specifically approved for the treatment of PTSD. Meta-analyses have shown Sertraline to be among the most effective and acceptable antidepressants for adults with MDD, solidifying its position as a preferred SSRI in many clinical scenarios.

Summarize any YouTube video in seconds

Get summaries like this one for any video, in your language, with the free Summ app.

Download on the App Store
Get it on Google Play

Transcript

Full transcript of “Sertraline Guide (Zoloft)”. Click a timestamp to open the video at that moment. Need another video? Use the YouTube transcript generator.

0:00 This talk is a guide to the psychiatric medication certuline. In this talk, I've attempted to put everything a psychiatrist needs to know about certuline on a single slide in less than 5 minutes. Certillene is also known by the brand name Zoloft, was first FDA approved in 1991 and often looks like a blue oval tablet. It is an SSRI anti-depressant and works primarily by inhibiting the serotonin transporter, thus increasing the neurotransmitter serotonin in the brain. Secondarily, it also inhibits the dopamine transporter and is an inverse agonist at the sigma 1 receptor. I consider it to be a low-risk medication and a lowcost medication. In adults, it is FDA approved for treatment of MDD, PMDD, social anxiety, OCD, panic

0:47 disorder, and PTSD. In children, it is FDA approved for OCD. However, it is often used off label for other indications. The usual dose range is 50 to 200 mg and the average halflife is 26 hours. Maximum therapeutic effects are usually not achieved until 4 to 6 weeks, but the initial onset of therapeutic action may be seen within 1 to 2 weeks. Withdrawal effects may occur and are uncomfortable but not life-threatening. To avoid withdrawal effects, I usually recommend reducing the dose of anti-depressants by no more than 50% every 1 week. It does not require monitoring in healthy individuals and is only a weak CYP2D6 inhibitor. Common side effects occur in the gastrointestinal genital urinary and neurologic organ systems as listed here.

1:35 The side effects that patients are usually most concerned about are weight gain, sedation, insomnia, GI side effects, and sexual side effects. Relative to other anti-depressants, certuline has a relatively higher incidence of insomnia and GI side effects. Rare but serious side effects are listed here. Its use is relatively contraindicated if the patient has an allergy to certuline or if the patient is concurrently taking dulfuram, lenazolid and mai anti-depressant, methylene blue, pimizide or thyoradine and it has a blackbox warning for increased suicidal thoughts and behaviors in children and young adults. Let's next review special cases. Certilline is cleared by the liver and requires dose reductions in patients with liver impairment. It generally does

2:20 not require dose adjustments in renal impairment. Certillene is a preferred anti-depressant in pregnant patients and is present in breast milk. Let's next discuss dosing. For simplicity, the doses given here are those used for MDD. I'll review the usual initial dose, maximum dose, goal dose, and titration schedule. Certillene may be dosed anywhere in the range of 25 to 400 mg. The initial dose is 50 mg for adults, 25 mg for 6 to 18y olds, and 25 mg for those 65 and older. The FDA maximum dose is 200 mg for both adults and children. For MDD and adults, the goal dose is 150 to 200 mg, but doses up to 300 mg have also been beneficial. For GAD in adults,

3:06 the goal dose is 50 to 150 mg. And for OCD and adults, the goal dose is 150 to 200 mg, but doses up to 400 mg have also been beneficial. For pediatric patients, the goal doses are generally lower. And for geriatric patients, the goal doses are the same as in adults. As you can see, in most cases, the goal dose will be from 50 to 200 mg. The usual titration schedule is 25 to 50 mg every week for adults and slower for children. I'd like to conclude with a few final tips. Certillene is the anti-depressant with the best evidence supporting its safety in patients with cardiac disease. So, it is preferred in these patients. It is also one of the only anti-depressants specifically approved for treatment of PTSD. Additionally, one

3:53 of the most rigorous meta analyses to date comparing different anti-depressants in the treatment of adults with MDD found that certuline was in the top 10 of most effective anti-depressants and in the top 10 of most acceptable anti-depressants. This makes it a preferred SSRI in many cases. That's the end of this talk. I hope this is a useful guide to certilline. Thank you.

Share

More video summaries